ClinicalTrials.Veeva

Menu

A Phase 2 Study of Home Care Following Autologous Hematopoietic Stem Cell Transplantation

Duke University logo

Duke University

Status

Enrolling

Conditions

Well-being of Caregivers (Caregiver Strain Index)

Treatments

Other: home care

Study type

Interventional

Funder types

Other

Identifiers

NCT03667599
Pro00089697

Details and patient eligibility

About

This is a research study to compare the well-being (caregiver strain index) of caregivers of patients receiving home vs standard care after autologous hematopoietic stem cell transplant.

Enrollment

150 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Patient Inclusion Criteria:

  • Scheduled to undergo an autologous hematopoietic stem cell transplant for any cancer or non-cancer illness
  • Age 18-80 years
  • Karnofsky Performance Scale KPS> 80
  • Able to read/write English
  • A home that is deemed, upon inspection, in suitable condition to serve as a medical home, within a 90-minute driving distance of Duke

Patient Exclusion Criteria:

  • Lack of a caregiver
  • Pregnant women
  • Patients with a documented active infection prior to starting their preparative regimen. This includes grade 3 or higher viral, bacterial, or fungal infection.
  • Use of homeopathic medications, prebiotics, or probiotics that may impact gut microbiota

Caregiver Inclusion Criteria:

  • Identified by patient as their primary caregiver
  • Meet standard clinical criteria for being a caregiver (able to drive and take care of patient)
  • Age 18-80 years

Caregiver Exclusion Criteria:

None

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

150 participants in 3 patient groups

Home care
Experimental group
Description:
This is the arm for patients who receive their transplant care in their homes.
Treatment:
Other: home care
Hospital Care
No Intervention group
Description:
Standard of care for stem cell transplant recipients where the aftercare is done in hospital.
Clinic Care
No Intervention group
Description:
Standard of care for stem cell transplant recipients who live at home but receive aftercare in the daily outpatient clinic.

Trial contacts and locations

1

Loading...

Central trial contact

Andrea Pires, MS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems